Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia
Amy E. DeZern(Johns Hopkins University), Robert A. Brodsky(Johns Hopkins University), Heather J. Symons(Johns Hopkins University), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Kenneth R. Cooke(Johns Hopkins University), Marianna Zahurak(Bloomberg (United States))
Cited by 132
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k